Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis
Phase 1
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: Placebo Saline Nasal SolutionDrug: Nasapaque Nasal Solution
- First Posted Date
- 2015-03-04
- Last Posted Date
- 2017-01-26
- Lead Sponsor
- 3E Therapeutics Corporation
- Target Recruit Count
- 73
- Registration Number
- NCT02377895
© Copyright 2025. All Rights Reserved by MedPath